NCT03866499 2024-08-07
A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients
Beta Pharma, Inc.
Phase 3 Active not recruiting
Clinical Trials
7 trialsNCT04390984 2021-01-11
Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT02976116 2019-11-15
A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer
Hutchmed
Phase 2 Completed
NCT04007835 2019-07-05
Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI
Guangdong Association of Clinical Trials
Phase NA Unknown
NCT03656393 2018-09-04
RCTACSCNSCLC
Shenzhen People's Hospital
Phase 3 Unknown
NCT00259064 2016-06-02
INSTEP
AstraZeneca
Phase 2/3 Completed
NCT02387086 2015-03-12
Gefitinib Combined With Thalidomide to Treat NSCLC
Shaanxi Provincial People's Hospital
Phase 2/3 Unknown